Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 Nov;66(781):894–905. doi: 10.1136/pgmj.66.781.894

Dermatology.

M H Rustin 1
PMCID: PMC2429766  PMID: 2148371

Full text

PDF
894

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adinoff A. D., Tellez P., Clark R. A. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol. 1988 Apr;81(4):736–742. doi: 10.1016/0091-6749(88)91047-0. [DOI] [PubMed] [Google Scholar]
  2. Armitage R. J., Goff L. K. Functional interaction between B cell subpopulations defined by CD23 expression. Eur J Immunol. 1988 Nov;18(11):1753–1760. doi: 10.1002/eji.1830181115. [DOI] [PubMed] [Google Scholar]
  3. Ashworth J., Booker J., Breathnach S. M. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol. 1988 Apr;118(4):457–469. doi: 10.1111/j.1365-2133.1988.tb02453.x. [DOI] [PubMed] [Google Scholar]
  4. Barker J. N., Alegre V. A., MacDonald D. M. Surface-bound immunoglobulin E on antigen-presenting cells in cutaneous tissue of atopic dermatitis. J Invest Dermatol. 1988 Feb;90(2):117–121. doi: 10.1111/1523-1747.ep12462074. [DOI] [PubMed] [Google Scholar]
  5. Barthelemy H., Frappaz A., Cambazard F., Mauduit G., Rouchouse B., Kanitakis J., Souteyrand P., Claudy A. L., Thivolet J. Treatment of nine cases of pemphigus vulgaris with cyclosporine. J Am Acad Dermatol. 1988 Jun;18(6):1262–1266. doi: 10.1016/s0190-9622(88)70132-2. [DOI] [PubMed] [Google Scholar]
  6. Basham T. Y., Nickoloff B. J., Merigan T. C., Morhenn V. B. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol. 1984 Aug;83(2):88–90. doi: 10.1111/1523-1747.ep12262597. [DOI] [PubMed] [Google Scholar]
  7. Bieber T., Dannenberg B., Ring J., Braun-Falco O. Keratinocytes in lesional skin of atopic eczema bear HLA-DR, CD1a and IgE molecules. Clin Exp Dermatol. 1989 Jan;14(1):35–39. doi: 10.1111/j.1365-2230.1989.tb00880.x. [DOI] [PubMed] [Google Scholar]
  8. Bieber T., Rieger A., Neuchrist C., Prinz J. C., Rieber E. P., Boltz-Nitulescu G., Scheiner O., Kraft D., Ring J., Stingl G. Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J Exp Med. 1989 Jul 1;170(1):309–314. doi: 10.1084/jem.170.1.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Birnstingl M. The Raynaud syndrome. Postgrad Med J. 1971 May;47(547):297–310. doi: 10.1136/pgmj.47.547.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bittiner S. B., Tucker W. F., Cartwright I., Bleehen S. S. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988 Feb 20;1(8582):378–380. doi: 10.1016/s0140-6736(88)91181-6. [DOI] [PubMed] [Google Scholar]
  11. Blumberg H., Wallin B. G. Direct evidence of neurally mediated vasodilatation in hairy skin of the human foot. J Physiol. 1987 Jan;382:105–121. doi: 10.1113/jphysiol.1987.sp016358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Blunt R. J., George A. J., Hurlow R. A., Strachan C. J., Stuart J. Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome. Br J Haematol. 1980 Aug;45(4):651–658. doi: 10.1111/j.1365-2141.1980.tb07188.x. [DOI] [PubMed] [Google Scholar]
  13. Bonnefoy J. Y., Aubry J. P., Peronne C., Wijdenes J., Banchereau J. Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE. J Immunol. 1987 May 1;138(9):2970–2978. [PubMed] [Google Scholar]
  14. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  15. Bos J. D., Meinardi M. M., van Joost T., Heule F., Powles A. V., Fry L. Use of cyclosporin in psoriasis. Lancet. 1989 Dec 23;2(8678-8679):1500–1502. doi: 10.1016/s0140-6736(89)92941-3. [DOI] [PubMed] [Google Scholar]
  16. Bos J. D. The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol. 1988 Feb;118(2):141–155. doi: 10.1111/j.1365-2133.1988.tb01768.x. [DOI] [PubMed] [Google Scholar]
  17. Bourne H. R., Lichtenstein L. M., Melmon K. L. Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3',5'-adenosine monophosphate in human leukocytes. J Immunol. 1972 Mar;108(3):695–705. [PubMed] [Google Scholar]
  18. Brain S. D., Tippins J. R., Williams T. J. Endothelin induces potent microvascular constriction. Br J Pharmacol. 1988 Dec;95(4):1005–1007. doi: 10.1111/j.1476-5381.1988.tb11731.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bruynzeel-Koomen C., van Wichen D. F., Toonstra J., Berrens L., Bruynzeel P. L. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278(3):199–205. doi: 10.1007/BF00412924. [DOI] [PubMed] [Google Scholar]
  20. Bruynzeel-Koomen C., van der Donk E. M., Bruynzeel P. L., Capron M., de Gast G. C., Mudde G. C. Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol. 1988 Oct;74(1):137–142. [PMC free article] [PubMed] [Google Scholar]
  21. Bunker C. B., Newton J. A., Kilborn J., Patel A., Conway G. S., Jacobs H. S., Greaves M. W., Dowd P. M. Most women with acne have polycystic ovaries. Br J Dermatol. 1989 Dec;121(6):675–680. doi: 10.1111/j.1365-2133.1989.tb08208.x. [DOI] [PubMed] [Google Scholar]
  22. Burton J. L. Diet and dermatology. BMJ. 1989 Mar 25;298(6676):770–771. doi: 10.1136/bmj.298.6676.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Burton J. L. Dietary fatty acids and inflammatory skin disease. Lancet. 1989 Jan 7;1(8628):27–31. doi: 10.1016/s0140-6736(89)91682-6. [DOI] [PubMed] [Google Scholar]
  24. Camilleri J. P., Fiessinger J. N., Debure C., Bruneval P., Tricottet V., Kazandjian S., Housset E. Fine structural capillary changes and basal lamina thickening in scleroderma (progressive systemic sclerosis) and Raynaud's disease. Pathol Res Pract. 1984 Jan;178(3):230–236. doi: 10.1016/S0344-0338(84)80104-1. [DOI] [PubMed] [Google Scholar]
  25. Camp R. D., Greaves M. W. Inflammatory mediators in the skin. Br Med Bull. 1987 Apr;43(2):401–414. doi: 10.1093/oxfordjournals.bmb.a072190. [DOI] [PubMed] [Google Scholar]
  26. Capron M., Jouault T., Prin L., Joseph M., Ameisen J. C., Butterworth A. E., Papin J. P., Kusnierz J. P., Capron A. Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages. J Exp Med. 1986 Jul 1;164(1):72–89. doi: 10.1084/jem.164.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chapkin R. S., Ziboh V. A. Inability of skin enzyme preparations to biosynthesize arachidonic acid from linoleic acid. Biochem Biophys Res Commun. 1984 Nov 14;124(3):784–792. doi: 10.1016/0006-291x(84)91026-x. [DOI] [PubMed] [Google Scholar]
  28. Clark R. A. Cell-mediated and IgE-mediated immune responses in atopic dermatitis. Arch Dermatol. 1989 Mar;125(3):413–416. [PubMed] [Google Scholar]
  29. Coffman J. D., Cohen A. S. Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med. 1971 Jul 29;285(5):259–263. doi: 10.1056/NEJM197107292850505. [DOI] [PubMed] [Google Scholar]
  30. Cookson W. O., Sharp P. A., Faux J. A., Hopkin J. M. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet. 1989 Jun 10;1(8650):1292–1295. doi: 10.1016/s0140-6736(89)92687-1. [DOI] [PubMed] [Google Scholar]
  31. Cotterill J. A., Cunliffe W. J., Williamson B., Bulusu L. Further observations on the pathogenesis of acne. Br Med J. 1972 Aug 19;3(5824):444–446. doi: 10.1136/bmj.3.5824.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cunliffe W. J., Shuster S. Pathogenesis of acne. Lancet. 1969 Apr 5;1(7597):685–687. doi: 10.1016/s0140-6736(69)92642-7. [DOI] [PubMed] [Google Scholar]
  33. Cunliffe W. J., Shuster S. The rate of sebum excretion in man. Br J Dermatol. 1969 Sep;81(9):697–704. doi: 10.1111/j.1365-2133.1969.tb16211.x. [DOI] [PubMed] [Google Scholar]
  34. Curley R. K., Macfarlane A. W., Vickers C. F. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol. 1985 Nov;113(5):601–604. doi: 10.1111/j.1365-2133.1985.tb02385.x. [DOI] [PubMed] [Google Scholar]
  35. Dahl M. G., McGibbon D. H. Complement C3 and immunoglobulin in inflammatory acne vulgaris. Br J Dermatol. 1979 Dec;101(6):633–640. doi: 10.1111/j.1365-2133.1979.tb05641.x. [DOI] [PubMed] [Google Scholar]
  36. Darley C. R., Kirby J. D., Besser G. M., Munro D. D., Edwards C. R., Rees L. H. Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol. 1982 May;106(5):517–522. doi: 10.1111/j.1365-2133.1982.tb04553.x. [DOI] [PubMed] [Google Scholar]
  37. Delespesse G., Sarfati M., Hofstetter H. Human IgE-binding factors. Immunol Today. 1989 May;10(5):159–164. doi: 10.1016/0167-5699(89)90173-4. [DOI] [PubMed] [Google Scholar]
  38. Deray G., Le Hoang P., Achour L., Hornych A., Landault C., Caraillon A. Cyclosporin and Raynaud phenomenon. Lancet. 1986 Nov 8;2(8515):1092–1093. doi: 10.1016/s0140-6736(86)90484-8. [DOI] [PubMed] [Google Scholar]
  39. Dintenfass L. Hemorheological factors in Raynaud's phenomenon. Angiology. 1977 Jul;28(7):472–481. doi: 10.1177/000331977702800705. [DOI] [PubMed] [Google Scholar]
  40. Downing D. T., Stewart M. E., Wertz P. W., Strauss J. S. Essential fatty acids and acne. J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):221–225. doi: 10.1016/s0190-9622(86)70025-x. [DOI] [PubMed] [Google Scholar]
  41. Eady E. A., Holland K. T., Cunliffe W. J. The use of antibiotics in acne therapy: oral or topical administration? J Antimicrob Chemother. 1982 Aug;10(2):89–115. doi: 10.1093/jac/10.2.89. [DOI] [PubMed] [Google Scholar]
  42. Edwards J. M., Phinney E. S., Taylor L. M., Jr, Keenan E. J., Porter J. M. Alpha 2-adrenergic receptor levels in obstructive and spastic Raynaud's syndrome. J Vasc Surg. 1987 Jan;5(1):38–45. [PubMed] [Google Scholar]
  43. Ellis C. N., Gorsulowsky D. C., Hamilton T. A., Billings J. K., Brown M. D., Headington J. T., Cooper K. D., Baadsgaard O., Duell E. A., Annesley T. M. Cyclosporine improves psoriasis in a double-blind study. JAMA. 1986 Dec 12;256(22):3110–3116. [PubMed] [Google Scholar]
  44. FULCO A. J., MEAD J. F. Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. J Biol Chem. 1959 Jun;234(6):1411–1416. [PubMed] [Google Scholar]
  45. Fagius J., Blumberg H. Sympathetic outflow to the hand in patients with Raynaud's phenomenon. Cardiovasc Res. 1985 May;19(5):249–253. doi: 10.1093/cvr/19.5.249. [DOI] [PubMed] [Google Scholar]
  46. Freedman R. R., Sabharal S. C., Desai N., Wenig P., Mayes M. Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease. Arthritis Rheum. 1989 Jan;32(1):61–65. doi: 10.1002/anr.1780320110. [DOI] [PubMed] [Google Scholar]
  47. Freinkel R. K. Pathogenesis of acne vulgaris. N Engl J Med. 1969 May 22;280(21):1161–1163. doi: 10.1056/NEJM196905222802106. [DOI] [PubMed] [Google Scholar]
  48. Furue M., Katz S. I. Direct effects of glucocorticosteroids on epidermal Langerhans cells. J Invest Dermatol. 1989 Mar;92(3):342–347. doi: 10.1111/1523-1747.ep12277165. [DOI] [PubMed] [Google Scholar]
  49. Gloor M., Graumann U., Kionke M., Wiegand I., Friederich H. C. Menge und Zusammensetzung der Hautoberflächenlipide bei Patienten mit Acne vulgaris und gesunden Vergleichspersonen. Arch Dermatol Forsch. 1972;242(3):316–322. [PubMed] [Google Scholar]
  50. Gondo A., Saeki N., Tokuda Y. Challenge reactions in atopic dermatitis after percutaneous entry of mite antigen. Br J Dermatol. 1986 Oct;115(4):485–493. doi: 10.1111/j.1365-2133.1986.tb06243.x. [DOI] [PubMed] [Google Scholar]
  51. Grewe S. R., Chan S. C., Hanifin J. M. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol. 1982 Dec;70(6):452–457. doi: 10.1016/0091-6749(82)90008-2. [DOI] [PubMed] [Google Scholar]
  52. Gupta A. K., Brown M. D., Ellis C. N., Rocher L. L., Fisher G. J., Baadsgaard O., Cooper K. D., Voorhees J. J. Cyclosporine in dermatology. J Am Acad Dermatol. 1989 Dec;21(6):1245–1256. doi: 10.1016/s0190-9622(89)70339-x. [DOI] [PubMed] [Google Scholar]
  53. Gupta A. K., Ellis C. N., Tellner D. C., Voorhees J. J. Cyclosporine A in the treatment of severe alopecia areata. Transplant Proc. 1988 Jun;20(3 Suppl 4):105–108. [PubMed] [Google Scholar]
  54. Hanifin J. M. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy. 1986 Feb;4(1):43–65. doi: 10.1007/BF02991187. [DOI] [PubMed] [Google Scholar]
  55. Harper J. I., Keat A. C., Staughton R. C. Cyclosporin for psoriasis. Lancet. 1984 Oct 27;2(8409):981–982. doi: 10.1016/s0140-6736(84)91194-2. [DOI] [PubMed] [Google Scholar]
  56. Hay J. B., Hodgins M. B. Metabolism of androgens by human skin in acne. Br J Dermatol. 1974 Aug;91(2):123–133. doi: 10.1111/j.1365-2133.1974.tb15857.x. [DOI] [PubMed] [Google Scholar]
  57. Heckmatt J., Hasson N., Saunders C., Thompson N., Peters A. M., Cambridge G., Rose M., Hyde S. A., Dubowitz V. Cyclosporin in juvenile dermatomyositis. Lancet. 1989 May 13;1(8646):1063–1066. doi: 10.1016/s0140-6736(89)92456-2. [DOI] [PubMed] [Google Scholar]
  58. Heidenheim M., Oxholm A., da Cunha Bang F. Generalized pustular psoriasis in relation to withdrawal of cyclosporin A. Br J Dermatol. 1990 May;122(5):719–719. doi: 10.1111/j.1365-2133.1990.tb07301.x. [DOI] [PubMed] [Google Scholar]
  59. Heslop J., Coggon D., Acheson E. D. The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J R Coll Gen Pract. 1983 Feb;33(247):85–89. [PMC free article] [PubMed] [Google Scholar]
  60. Ho V. C., Griffiths C. E., Ellis C. N., Gupta A. K., McCuaig C. C., Nickoloff B. J., Cooper K. D., Hamilton T. A., Voorhees J. J. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study. J Am Acad Dermatol. 1990 Jan;22(1):94–100. doi: 10.1016/0190-9622(90)70015-a. [DOI] [PubMed] [Google Scholar]
  61. Ho V. C., Gupta A. K., Ellis C. N., Cooper K. D., Nickoloff B. J., Voorhees J. J. Cyclosporine in lamellar ichthyosis. Arch Dermatol. 1989 Apr;125(4):511–514. [PubMed] [Google Scholar]
  62. Horrobin D. F. Essential fatty acids in clinical dermatology. J Am Acad Dermatol. 1989 Jun;20(6):1045–1053. doi: 10.1016/s0190-9622(89)70130-4. [DOI] [PubMed] [Google Scholar]
  63. Jahnsen T., Nielsen S. L., Skovborg F. Blood viscosity and local response to cold in primary Raynaud's phenomenon. Lancet. 1977 Nov 12;2(8046):1001–1002. doi: 10.1016/s0140-6736(77)92895-1. [DOI] [PubMed] [Google Scholar]
  64. Jones D. W., Snaith M. L., Isenberg D. A. Cyclosporine treatment for intractable polymyositis. Arthritis Rheum. 1987 Aug;30(8):959–960. doi: 10.1002/art.1780300825. [DOI] [PubMed] [Google Scholar]
  65. Kahaleh M. B., Osborn I., LeRoy E. C. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med. 1981 Apr;94(4 Pt 1):482–484. doi: 10.7326/0003-4819-94-4-482. [DOI] [PubMed] [Google Scholar]
  66. Kanaar P. Follicular-keratogenic properties of fatty acids in the external ear canal of the rabbit. Dermatologica. 1971;142(1):14–22. doi: 10.1159/000252365. [DOI] [PubMed] [Google Scholar]
  67. Kanaar P. Lipolysis of skin-surface lipids of acne vulgaris patients and healthy controls. Dermatologica. 1971;143(2):121–129. doi: 10.1159/000252180. [DOI] [PubMed] [Google Scholar]
  68. Kersey P., Sussman M., Dahl M. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol. 1980 Dec;103(6):651–655. doi: 10.1111/j.1365-2133.1980.tb01687.x. [DOI] [PubMed] [Google Scholar]
  69. Kligman A. M. An overview of acne. J Invest Dermatol. 1974 Mar;62(3):268–287. doi: 10.1111/1523-1747.ep12676801. [DOI] [PubMed] [Google Scholar]
  70. Knutson D. D. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol. 1974 Mar;62(3):288–307. doi: 10.1111/1523-1747.ep12676804. [DOI] [PubMed] [Google Scholar]
  71. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208(5):401–406. [PubMed] [Google Scholar]
  72. Larsen F. S., Holm N. V., Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1986 Sep;15(3):487–494. [PubMed] [Google Scholar]
  73. Lawrence D. M., Katz M., Robinson T. W., Newman M. C., McGarrigle H. H., Shaw M., Lachelin G. C. Reduced sex hormone binding globulin and derived free testosterone levels in women with severe acne. Clin Endocrinol (Oxf) 1981 Jul;15(1):87–91. doi: 10.1111/j.1365-2265.1981.tb02752.x. [DOI] [PubMed] [Google Scholar]
  74. Lee P., Norman C. S., Sukenik S., Alderdice C. A. The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma). J Rheumatol. 1985 Jun;12(3):514–517. [PubMed] [Google Scholar]
  75. Lee W. L., Shalita A. R., Suntharalingam K., Fikrig S. M. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun. 1982 Jan;35(1):71–78. doi: 10.1128/iai.35.1.71-78.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Leeming J. P., Holland K. T., Cuncliffe W. J. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol. 1988 Feb;118(2):203–208. doi: 10.1111/j.1365-2133.1988.tb01775.x. [DOI] [PubMed] [Google Scholar]
  77. Leeming J. P., Holland K. T., Cunliffe W. J. The microbial ecology of pilosebaceous units isolated from human skin. J Gen Microbiol. 1984 Apr;130(4):803–807. doi: 10.1099/00221287-130-4-803. [DOI] [PubMed] [Google Scholar]
  78. Leeming J. P., Holland K. T., Cunliffe W. J. The pathological and ecological significance of microorganisms colonizing acne vulgaris comedones. J Med Microbiol. 1985 Aug;20(1):11–16. doi: 10.1099/00222615-20-1-11. [DOI] [PubMed] [Google Scholar]
  79. Leung D. Y., Geha R. S. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy. 1986 Feb;4(1):67–86. doi: 10.1007/BF02991188. [DOI] [PubMed] [Google Scholar]
  80. Leyden J. J., McGinley K. J., Mills O. H., Kligman A. M. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 1975 Oct;65(4):382–384. doi: 10.1111/1523-1747.ep12607634. [DOI] [PubMed] [Google Scholar]
  81. Manku M. S., Horrobin D. F., Morse N. L., Wright S., Burton J. L. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol. 1984 Jun;110(6):643–648. doi: 10.1111/j.1365-2133.1984.tb04698.x. [DOI] [PubMed] [Google Scholar]
  82. Manku M. S., Horrobin D. F., Morse N., Kyte V., Jenkins K., Wright S., Burton J. L. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot Med. 1982 Dec;9(6):615–628. doi: 10.1016/0262-1746(82)90019-1. [DOI] [PubMed] [Google Scholar]
  83. Maricq H. R., Weinrich M. C., Keil J. E., LeRoy E. C. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis. 1986;39(6):423–427. doi: 10.1016/0021-9681(86)90109-8. [DOI] [PubMed] [Google Scholar]
  84. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet. 1989 May 20;1(8647):1093–1096. doi: 10.1016/s0140-6736(89)92381-7. [DOI] [PubMed] [Google Scholar]
  85. Maurice P. D., Allen B. R., Barkley A. S., Cockbill S. R., Stammers J., Bather P. C. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol. 1987 Nov;117(5):599–606. doi: 10.1111/j.1365-2133.1987.tb07492.x. [DOI] [PubMed] [Google Scholar]
  86. McGinley K. J., Webster G. F., Leyden J. J. Regional variations of cutaneous propionibacteria. Appl Environ Microbiol. 1978 Jan;35(1):62–66. doi: 10.1128/aem.35.1.62-66.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Melnik B. C., Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):557–563. doi: 10.1016/s0190-9622(89)70226-7. [DOI] [PubMed] [Google Scholar]
  88. Mitchell E. B., Crow J., Chapman M. D., Jouhal S. S., Pope F. M., Platts-Mills T. A. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet. 1982 Jan 16;1(8264):127–130. doi: 10.1016/s0140-6736(82)90379-8. [DOI] [PubMed] [Google Scholar]
  89. Morello A. M., Downing D. T., Strauss J. S. Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol. 1976 May;66(5):319–323. doi: 10.1111/1523-1747.ep12482300. [DOI] [PubMed] [Google Scholar]
  90. Morse P. F., Horrobin D. F., Manku M. S., Stewart J. C., Allen R., Littlewood S., Wright S., Burton J., Gould D. J., Holt P. J. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol. 1989 Jul;121(1):75–90. doi: 10.1111/j.1365-2133.1989.tb01403.x. [DOI] [PubMed] [Google Scholar]
  91. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol. 1983 Aug;109(2):191–198. doi: 10.1111/j.1365-2133.1983.tb07080.x. [DOI] [PubMed] [Google Scholar]
  92. Mueller W., Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979 Sep 6;301(10):555–555. doi: 10.1056/NEJM197909063011016. [DOI] [PubMed] [Google Scholar]
  93. Norris J. F., Cunliffe W. J. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988 May;118(5):651–659. doi: 10.1111/j.1365-2133.1988.tb02566.x. [DOI] [PubMed] [Google Scholar]
  94. Norris P. G., Schofield O., Camp R. D. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol. 1988 Mar;118(3):435–440. doi: 10.1111/j.1365-2133.1988.tb02440.x. [DOI] [PubMed] [Google Scholar]
  95. Nussenblatt R. B., Palestine A. G., Chan C. C., Mochizuki M., Yancey K. Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum. 1985 Jun;28(6):671–679. doi: 10.1002/art.1780280611. [DOI] [PubMed] [Google Scholar]
  96. O'Loughlin S., Diaz-Perez J. L., Gleich G. J., Winkelmann R. K. Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol. 1977 Mar;113(3):309–315. [PubMed] [Google Scholar]
  97. PEACOCK J. H. A comparative study of the digital cutaneous temperatures and hand blood flows in the normal hand, primary Raynaud's disease and primary acrocyanosis. Clin Sci. 1959 Feb;18(1):25–33. [PubMed] [Google Scholar]
  98. PETERSON R. D., PAGE A. R., GOOD R. A. Wheal and erythema allergy in patients with agammaglobulinemia. J Allergy. 1962 Sep-Oct;33:406–411. doi: 10.1016/0021-8707(62)90045-x. [DOI] [PubMed] [Google Scholar]
  99. Paulsrud J. R., Pensler L., Whitten C. F., Stewart S., Holman R. T. Essential fatty acid deficiency in infants induced by fat-free intravenous feeding. Am J Clin Nutr. 1972 Sep;25(9):897–904. doi: 10.1093/ajcn/25.9.897. [DOI] [PubMed] [Google Scholar]
  100. Pigatto P. D., Chiappino G., Bigardi A., Mozzanica N., Finzi A. F. Cyclosporin A for treatment of severe lichen planus. Br J Dermatol. 1990 Jan;122(1):121–123. doi: 10.1111/j.1365-2133.1990.tb08255.x. [DOI] [PubMed] [Google Scholar]
  101. Platts-Mills T. A., Mitchell E. B., Rowntree S., Chapman M. D., Wilkins S. R. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol. 1983 May;8(3):233–247. doi: 10.1111/j.1365-2230.1983.tb01776.x. [DOI] [PubMed] [Google Scholar]
  102. Prottey C., Hartop P. J., Press M. Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower-seed oil to the skin. J Invest Dermatol. 1975 Apr;64(4):228–234. doi: 10.1111/1523-1747.ep12510667. [DOI] [PubMed] [Google Scholar]
  103. Puhvel S. M., Amirian D. A. Bacterial flora of comedones. Br J Dermatol. 1979 Nov;101(5):543–548. doi: 10.1111/j.1365-2133.1979.tb11883.x. [DOI] [PubMed] [Google Scholar]
  104. Puhvel S. M., Hoffman I. K., Sternberg T. H. Corynebacterium acnes. Presence of complement fixing antibodies to corynebacterium acnes in the sera of patients with acne vulgaris. Arch Dermatol. 1966 Mar;93(3):364–366. doi: 10.1001/archderm.93.3.364. [DOI] [PubMed] [Google Scholar]
  105. Puhvel S. M., Sakamoto M. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis). J Invest Dermatol. 1980 Jan;74(1):36–39. doi: 10.1111/1523-1747.ep12514592. [DOI] [PubMed] [Google Scholar]
  106. Reilly I. A., Roy L., Fitzgerald G. A. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) 1986 Apr 19;292(6527):1037–1039. doi: 10.1136/bmj.292.6527.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Reitamo S., Visa K., Kähönen K., Käyhkö K., Stubb S., Salo O. P. Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens. Br J Dermatol. 1986 Mar;114(3):303–309. doi: 10.1111/j.1365-2133.1986.tb02821.x. [DOI] [PubMed] [Google Scholar]
  108. Rustin M. H., Bull H. A., Machin S. J., Koro O., Dowd P. M. Serum from patients with Raynaud's phenomenon inhibits prostacyclin production. J Invest Dermatol. 1987 Dec;89(6):555–559. doi: 10.1111/1523-1747.ep12461206. [DOI] [PubMed] [Google Scholar]
  109. Rustin M. H., Kovacs I. B., Sowemimo-Coker S. O., Maddison P. J., Kirby J. D. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease. Br J Dermatol. 1985 Sep;113(3):265–272. doi: 10.1111/j.1365-2133.1985.tb02077.x. [DOI] [PubMed] [Google Scholar]
  110. Rösch J., Porter J. M., Gralino B. J. Cryodynamic hand angiography in the diagnosis and management of Raynaud's syndrome. Circulation. 1977 May;55(5):807–814. doi: 10.1161/01.cir.55.5.807. [DOI] [PubMed] [Google Scholar]
  111. SINCLAIR H. M. Essential fatty acids and the skin. Br Med Bull. 1958 Sep;14(3):258–262. doi: 10.1093/oxfordjournals.bmb.a069693. [DOI] [PubMed] [Google Scholar]
  112. Saarinen U. M. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol. 1984 Aug;74(2):196–200. doi: 10.1016/0091-6749(84)90286-0. [DOI] [PubMed] [Google Scholar]
  113. Saint-Leger D., Bague A., Cohen E., Chivot M. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br J Dermatol. 1986 May;114(5):535–542. doi: 10.1111/j.1365-2133.1986.tb04060.x. [DOI] [PubMed] [Google Scholar]
  114. Saint-Leger D., Bague A., Lefebvre E., Cohen E., Chivot M. A possible role for squalene in the pathogenesis of acne. II. In vivo study of squalene oxides in skin surface and intra-comedonal lipids of acne patients. Br J Dermatol. 1986 May;114(5):543–552. doi: 10.1111/j.1365-2133.1986.tb04061.x. [DOI] [PubMed] [Google Scholar]
  115. Samuelsson B., Goldyne M., Granström E., Hamberg M., Hammarström S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997–1029. doi: 10.1146/annurev.bi.47.070178.005025. [DOI] [PubMed] [Google Scholar]
  116. Schiavone F. E., Rietschel R. L., Sgoutas D., Harris R. Elevated free testosterone levels in women with acne. Arch Dermatol. 1983 Oct;119(10):799–802. [PubMed] [Google Scholar]
  117. Shalita A. R. Genesis of free fatty acids. J Invest Dermatol. 1974 Mar;62(3):332–335. doi: 10.1111/1523-1747.ep12724289. [DOI] [PubMed] [Google Scholar]
  118. Sharpe G. R., Farr P. M. Evening primrose oil and eczema. Lancet. 1990 Mar 17;335(8690):667–668. doi: 10.1016/0140-6736(90)90459-i. [DOI] [PubMed] [Google Scholar]
  119. Shawket S., Dickerson C., Hazleman B., Brown M. J. Selective suprasensitivity to calcitonin-gene-related peptide in the hands in Raynaud's phenomenon. Lancet. 1989 Dec 9;2(8676):1354–1357. doi: 10.1016/s0140-6736(89)91966-1. [DOI] [PubMed] [Google Scholar]
  120. Sheehan-Dare R. A., Hughes B. R., Cunliffe W. J. Clinical markers of androgenicity in acne vulgaris. Br J Dermatol. 1988 Dec;119(6):723–730. doi: 10.1111/j.1365-2133.1988.tb03494.x. [DOI] [PubMed] [Google Scholar]
  121. Stewart P. M., Shackleton C. H., Beastall G. H., Edwards C. R. 5 alpha-reductase activity in polycystic ovary syndrome. Lancet. 1990 Feb 24;335(8687):431–433. doi: 10.1016/0140-6736(90)90664-q. [DOI] [PubMed] [Google Scholar]
  122. Stone S. P., Muller S. A., Gleich G. J. IgE levels in atopic dermatitis. Arch Dermatol. 1973 Dec;108(6):806–811. [PubMed] [Google Scholar]
  123. Taylor R. S., 3rd, Cooper K. D., Headington J. T., Ho V. C., Ellis C. N., Voorhees J. J. Cyclosporine therapy for severe atopic dermatitis. J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):580–583. doi: 10.1016/s0190-9622(89)80236-1. [DOI] [PubMed] [Google Scholar]
  124. Thivolet J., Barthelemy H., Rigot-Muller G., Bendelac A. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet. 1985 Feb 9;1(8424):334–335. doi: 10.1016/s0140-6736(85)91099-2. [DOI] [PubMed] [Google Scholar]
  125. Thorley-Lawson D. A., Nadler L. M., Bhan A. K., Schooley R. T. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol. 1985 May;134(5):3007–3012. [PubMed] [Google Scholar]
  126. Vanhoutte P. M. The endothelium--modulator of vascular smooth-muscle tone. N Engl J Med. 1988 Aug 25;319(8):512–513. doi: 10.1056/NEJM198808253190809. [DOI] [PubMed] [Google Scholar]
  127. Velthuis P. J., Jesserun R. F. Improvement of ichthyosis by cyclosporin. Lancet. 1985 Feb 9;1(8424):335–335. doi: 10.1016/s0140-6736(85)91100-6. [DOI] [PubMed] [Google Scholar]
  128. Webster G. F., Leyden J. J., Norman M. E., Nilsson U. R. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun. 1978 Nov;22(2):523–529. doi: 10.1128/iai.22.2.523-529.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Wene J. D., Connor W. E., DenBesten L. The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally. J Clin Invest. 1975 Jul;56(1):127–134. doi: 10.1172/JCI108061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Williams M., Cunliffe W. J. Explanation for premenstrual acne. Lancet. 1973 Nov 10;2(7837):1055–1057. doi: 10.1016/s0140-6736(73)92661-5. [DOI] [PubMed] [Google Scholar]
  131. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  132. Yukawa K., Kikutani H., Owaki H., Yamasaki K., Yokota A., Nakamura H., Barsumian E. L., Hardy R. R., Suemura M., Kishimoto T. A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes. J Immunol. 1987 Apr 15;138(8):2576–2580. [PubMed] [Google Scholar]
  133. Zachariae H., Halkier-Sørensen L., Heickendorff L., Zachariae E., Hansen H. E. Cyclosporin A treatment of systemic sclerosis. Br J Dermatol. 1990 May;122(5):677–681. doi: 10.1111/j.1365-2133.1990.tb07290.x. [DOI] [PubMed] [Google Scholar]
  134. Zachary C. B., Allen M. H., MacDonald D. M. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol. 1985 Feb;112(2):149–156. doi: 10.1111/j.1365-2133.1985.tb00078.x. [DOI] [PubMed] [Google Scholar]
  135. van Joost T., Stolz E., Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol. 1987 Feb;123(2):166–167. doi: 10.1001/archderm.123.2.166. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES